ABCL – abcellera biologics inc. - common shares (US:NASDAQ)

News

AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
AbCellera Reports Full Year 2025 Business Results
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at Wall Stree
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com